GxPlex

21 CFR Part 211

21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals

in force

Last verified: Last observed: SHA-256: 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa

Resolution: api backed

Authority
US Food and Drug Administration
Jurisdiction
US
Status
in force
Effective date
—
Last changed
—
Last verified
:
Watch cadence
weekly
Crawlable
yes · renders server-side
Text licence
freely reproducible
Primary source
Primary source (opens in new tab) ecfr.gov
Topics
CGMP · records · automatic equipment · laboratory records

Current status#

Recorded as in-force against the primary source on 1 August 2026.

The text that supported that record, retrieved 1 August 2026 by structured:

78 codified version(s); most recent amendment 2025-12-18 (211.1)

Found at: eCFR versioner API — codified amendment history

Observation history#

First observed 31 July 2026. Last observed 3 August 2026. 13 observation(s) recorded.

13 of those returned a document to a standard HTTP client and produced a content hash.

No change to the retrieved text has been detected since observation began.

Sources#

Cite this instrument

Each format carries the permalink and the date this instrument was observed. The observation date is part of the citation: the underlying source may have changed since.

Plain text

GxPlex. 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals [instrument record]. Observed 1 August 2026. https://gxplex.com/instrument/us-21-cfr-part-211 Primary source: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211

BibTeX

@misc{gxplexinstrumentus21cfrpart211,
  author       = {{GxPlex}},
  title        = {{21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals}},
  year         = {2026},
  note         = {instrument record, observed 1 August 2026},
  howpublished = {\url{https://gxplex.com/instrument/us-21-cfr-part-211}},
  urldate      = {2026-08-01},
  url          = {https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211}
}

APA

GxPlex. (2026). 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals [instrument record]. Retrieved 1 August 2026, from https://gxplex.com/instrument/us-21-cfr-part-211

Observation history

Observed on 13 occasion(s) since 2026-07-31. 13 produced a content hash.

·············

One mark per observation, oldest first. · unchanged · ! content changed · ~ fetched but rendered client-side, no hash · × could not be fetched, no hash.

First observed
2026-07-31
Last observed
2026-08-03 (HTTP 200)
Fetch method
direct
Current hash
393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa

Subject and class (as stated)

The words this document uses about itself, matched verbatim against its own title. Not a statement of scope, and not a judgment about which organisations or products fall under it: each value quotes the span it was read from and links to where that span was read.

Citations (within the tracked corpus)

One document's retained text contained a form another document is published under, on the date shown, with the words it was read from. This records that one document names another and states nothing about the relationship between their requirements, or the manner of the citation — a document naming another in order to exclude it produces the same entry as one adopting it.

These citations are drawn together on the citation graph, where every row carries the same quote and source.

Cited by (within the tracked corpus)

Other instruments addressing the same subjects

A citation index only: both documents address the subject. This states no relationship between their requirements.

Sources

Last updated: